Testing effectiveness (Phase 2)Study completedNCT00047216What this trial is testingTipifarnib in Treating Patients With Recurrent Bladder CancerWho this might be right forBladder Cancer University Health Network, Toronto
Not applicableUnknownNCT05643807What this trial is testingBladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better?Who this might be right forBladder Cancer Centre Hospitalier Universitaire Vaudois 414
Testing effectiveness (Phase 2)Active Not RecruitingNCT02202772What this trial is testingIntravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the BladderWho this might be right forUrothelial Carcinoma of the Urinary Bladder Guarionex J. Decastro 51
Early research (Phase 1)WithdrawnNCT03430687What this trial is testingTalimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell CarcinomaWho this might be right forStage 0 Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more University of California, San Francisco
Testing effectiveness (Phase 2)Ended earlyNCT01353222What this trial is testingDN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial CarcinomaWho this might be right forUrothelial Carcinoma Dendreon 142
Testing effectiveness (Phase 2)Study completedNCT01828736What this trial is testingEfficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial CarcinomaWho this might be right forRecurrent Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 61
Testing effectiveness (Phase 2)Study completedNCT00053209What this trial is testingPemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 46
Not applicableStudy completedNCT06818799What this trial is testingThulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder CancerWho this might be right forBladder Transitional Cell Carcinoma Helwan University 50
Testing effectiveness (Phase 2)Ended earlyNCT00112905What this trial is testingSorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumWho this might be right forAdenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06305767What this trial is testingA Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)Who this might be right forBladder Cancer Merck Sharp & Dohme LLC 230
Testing effectiveness (Phase 2)Study completedNCT00041106What this trial is testingGefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder CancerWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter National Cancer Institute (NCI) 50
Early research (Phase 1)Ended earlyNCT03915405What this trial is testingKHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder CancerWho this might be right forUrothelial Carcinoma Kyowa Kirin, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT04311580What this trial is testingIntravesical Electromotive Mitomycin After Bacillus Calmette-Guérin FailureWho this might be right forBladder Cancer University of Rome Tor Vergata 52
Testing effectiveness (Phase 2)Study completedNCT00077688What this trial is testingTOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the UrotheliumWho this might be right forBladder NeoplasmsUreteral NeoplasmsUrethral Neoplasms+1 more Achieve Life Sciences 44
Not applicableLooking for participantsNCT06394869What this trial is testingStudy to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.Who this might be right forHematuria - Cause Not Known Pacific Edge Limited 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04579224What this trial is testingComparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial CancerWho this might be right forMetastatic Bladder Urothelial CarcinomaMetastatic Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+2 more National Cancer Institute (NCI) 184
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Very early researchStudy completedNCT01240824What this trial is testingStudy of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder CancerWho this might be right forBladder Cancer University of Virginia 3
Not applicableLooking for participantsNCT06138561What this trial is testingManagement of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric AssessmentsWho this might be right forBladder CancerMetastatic Bladder CancerUnresectable Bladder Carcinoma+1 more Dana-Farber Cancer Institute 180
Not applicableStudy completedNCT07642102What this trial is testingEvaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder CancerWho this might be right forBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Transurethral Resection of Bladder Tumor Ain Shams University 70